Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
ARNA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading ARNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.27%155.011.1%$478.85m
GILDGilead Sciences, Inc.
-0.09%64.500.9%$468.51m
REGNRegeneron Pharmaceuticals, Inc.
-0.12%455.172.7%$416.76m
CELGCelgene Corporation
0.03%116.781.1%$407.52m
ALXNAlexion Pharmaceuticals, Inc.
-0.81%97.701.9%$373.58m
BIIBBiogen Inc.
-0.86%250.801.2%$355.62m
INCYIncyte Corporation
-2.91%134.382.6%$286.18m
PBYIPuma Biotechnology, Inc.
2.18%79.7521.1%$224.97m
VRTXVertex Pharmaceuticals Incorporated
1.11%119.921.9%$192.01m
ILMNIllumina, Inc.
1.24%175.913.5%$175.81m
AAgilent Technologies, Inc.
0.35%59.511.5%$135.41m
EXASExact Sciences Corporation
0.39%33.3228.0%$128.17m
TSROTESARO, Inc.
-2.66%149.1114.7%$108.95m
KITEKite Pharma, Inc.
-2.40%73.1116.1%$106.96m
BMRNBioMarin Pharmaceutical Inc.
0.77%88.004.4%$97.75m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.